Business
Cannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System
Cannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System\nPR Newswire\nBETHESDA, Maryland, June 6, 2016\n\n\n\nBETHESDA, Maryland, June 6, 2016 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) filed a PCT Application with the US Patent & Trademark Office (USPTO) entitled a \"System and Method for High Throughput Screening of Cancer Cells\".  \n\n\nCannabics Pharmaceuticals has developed a proprietary high throughput screening process which is designed to generate mega-data of specific cannabinoids and cannabinoid formulations with antitumor properties. In this proprietary process biopsies and live cancer cells lines are treated, In vitro, with innumerous combinations of cannabinoids and the resulting antitumor effects are screened, categorized and actually visually displayed.  Dr. Eyal Ballan, Chief scientist of the company said: \"This data enables doctors to provide a personalized and tailored therapy to cancer patients with the potential of reducing the tumor itself.\"\n\nCannabics Pharmaceuticals plans to license this technology globally, wherever cancer patients have access to regulated medical cannabis.  To this effect it is already in preliminary negotiations with premier oncology laboratories in Illinois, Colorado California, Oregon, as well as several other US and European jurisdictions. \n\nAbout Cannabics Pharmaceuticals Inc.\n\nCannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the proven therapeutic properties of natural Cannabinoids. Cannabics' vision is to create tailored therapies for cancer patients, utilizing advanced HTS technology and personalized bioinformatics tools. The Company's R&D is based in Israel, where it is fully licensed by the Ministry of Health and i...